Optimal Design of Paired Built Environment Interventions for Control of MDROs in Acute Care and Community Hospitals. (April 2021)

• Record Type: Journal Article
• Authors: Squire, Marietta M.; Sessel, Gareth K.; Lin, Gary; Squire, Edward N.; Igusa, Takeru
• Is Part Of: HERD. Volume 14:Number 2(2021)
• Page Start: 109
• Page End: 129
• Publication Date: 2021-04
• Subjects: built environment -- patient safety -- cost savings -- healthcare-associated infection -- hospital -- direct cost -- multidrug-resistant organism -- MRSA -- CRE -- VRE -- quality improvement -- infection control -- colonized -- admissions -- handwashing -- cleaning; Health facilities -- Design and construction -- Periodicals; Medical care -- Periodicals; Health facilities -- Design and construction; Medical care; Periodicals; 725.5
• DOI: 10.1177/1937586720976585
• Languages: English
• ISSNs: 1937-5867

Abstract

Objectives: Our goal was to optimize infection control of paired environmental control interventions within hospitals to reduce methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacteriaceae (CRE), and vancomycin-resistant Enterococci (VRE). Background: The most widely used infection control interventions are deployment of handwashing (HW) stations, control of relative humidity (RH), and negative pressure (NP) treatment rooms. Direct costs of multidrug-resistant organism (MDRO) infections are typically not included in the design of such interventions. Methods: We examined the effectiveness of pairing HW with RH and HW with NP. We used the following three data sets: A meta-analysis of progression rates from uncolonized to colonized to infected, 6 years of MDRO treatment costs from 400 hospitals, and 8 years of MDRO incidence rates at nine army hospitals. We used these data as inputs into an Infection De-Escalation Model with varying budgets to obtain optimal intervention designs. We then computed the infection and prevention rates and cost savings resulting from these designs. Results: The average direct cost of an MDRO infection was $3, 289, $1, 535, and $1, 067 for MRSA, CRE, and VRE. The mean annual incidence rates per facility were 0.39%, 0.034%, and 0.011% for MRSA, CRE, and VRE. After applying the cost-minimizing intervention pair to each scenario, the percentage reductions in infections (and annual direct cost savings) in large, community, and small acute care hospitals were 69% ($1.5 million), 73% ($631K), 60% ($118K) for MRSA, 52% ($460.5K), 58% ($203K), 50% ($37K) for CRE, and 0%, 0%, and 50% ($12.8K) for VRE. Conclusion: The application of this Infection De-Escalation Model can guide cost-effective decision making in hospital built environment design to improve control of MDRO infections.